Association between sleep quality with maternal and neonatal outcomes during the covid-19 pandemic

Table 2 Correlation of sleep disorders with maternal and newborn outcomes in two groups

Variable	No sleep disorders group n = 99 Mean ± SD	PSQI Correlation coefficient	P-value	Sleep disorders group n = 99 Mean ± SD	PSQI Correlation coefficient	P-value
FBS 24–28 week (mg/dl)	80.21 ± 7.39	-0.04 ^b	0.67	93.68 ± 7.71	0.26 ^a	0. 47
FBS 34–36 week (mg/dl)	79.66 ± 8.85	0.03 ^a	0.42	95.86 ± 10.11	0.33 ^a	0.001 *
CDA	7.39 ± 5.73	0.01 ^a	0.27	11.91 ± 9.20	0.35 ^b	0.001*
LFPL (min)	156.25 ± 64.31	0.47 ^a	0.78	173.21 ± 78.50	0.016 ^a	0.89
LSPL (min)	22.92 ± 11.91	0.14 ^b	0.41	25.00 ± 13.15	0.15 ^a	0.35
Birth Weight (g)	3318.33 ± 47.96	0.30 ^a	0.76	3270.11 ± 41.73	0.13 ^a	0.18
Apgar 1st min	8.77 ± 0.47	-0.18 ^b	0.06	8.86 ± 0.35	0.033 ^b	0. 74
Apgar 5th min	9.95 ± 0.26	-0.05 ^b	0.96	9.98 ± 0.14	0.082 ^b	0.39

^a Pearson correlation (r)
^bSpearman’s correlation(rho)
*P < 0.05
PSQI; Pittsburgh Sleep Quality Index, FBS; Fast Blood SugarCDA; Corona Disease Anxiety, LFPL; length of the First Phase of Labor, LSPL; length of the Second Phase of Labor, g; gram, min; minute

ISSN: 1471-2393